News

November 17, 2016November 17, 2016

Switching to Zavesca Treatment Improved Gaucher Disease Patient’s Symptoms in Case Study

News

A man with type 1 Gaucher disease benefited after switching treatments to Zavesca (miglustat) from Cerezyme (imiglucerase), according to a case study. The report, “Successful Switch From Enzyme Replacement Therapy To ... Read more

November 15, 2016

MRI Allows Reliable Identification of Bone Lesions In Gaucher Patients

News

Magnetic resonance imaging (MRI) can be a resourceful tool to identify bone lesions in Gaucher disease (GD) patients, according to a new study. The research paper, “The Utility Of Magnetic ... Read more

November 10, 2016

Imiglucerase is Still the Enzyme of Choice for Type 1 Gaucher Disease

News

Imiglucerase (Cerezyme) has an excellent track record in treating type 1 Gaucher disease, according to a recent review that analyzed 26 years worth of publications on the topic. The study, ... Read more

November 8, 2016

Progranulin Seen to Improve Gaucher Disease in Mice

News

Researchers from New York University School of Medicine recently found that treating a mouse model of Gaucher disease with a key part of the protein progranulin led to marked improvement. The finding ... Read more

November 3, 2016November 3, 2016

Unusual Movement Disorder Seen in Group of Gaucher Type 3 Patients in Sweden

News

A Swedish group of Gaucher patients showed clinical features never previously reported in this disease — a rapid and repetitive dystonia-like hyperkinetic movement disorder that may be unique to this group of people, researchers reported. ... Read more

October 27, 2016October 27, 2016

Artificial Protein Could Be New Therapeutic Tool for Gaucher Disease

News

An artificial version of the protein progranulin could reverse most cellular defects found in Gaucher disease, according to study led by researchers at NYU Langone Medical Center. Gaucher disease (GD), a rare ... Read more

October 25, 2016October 25, 2016

Rare but Benign Complication of Gaucher Disease Seen in Case Study

News

A team of researchers from Peking Union Medical College Hospital in Beijing, China reported the rare case of patient diagnosed with Gaucher Disease who developed mesenteric lymphadenopathy, or an inflammation ... Read more

October 20, 2016

Animal Study Shows Gaucher Disease Linked to Progressive Neurological, Behavioral Changes

News

Understanding the progressive changes associated with Gaucher disease (GD) may provide useful information to develop more effective therapies. In recent research, scientists at Cincinnati Children’s Hospital Medical Center used mice to ... Read more

October 18, 2016October 18, 2016

Gaucher Patients on VPRIV Can Safely Switch to Cerdelga or Cerezyme, Study Finds

News

Patients with type 1 Gaucher disease being treated with VPRIV (velaglucerase alfa) can safely transition to Cerdelga (eliglustat) or Cerezyme (imiglucerase) and maintain clinical stability, according to a new study that draws ... Read more

October 13, 2016October 13, 2016

Restoring Faulty Protein Production May Improve Gaucher Disease Symptoms, Study Finds

News

Targeting mitochondrial dysfunction and the improper production of glucocerebrosidase, the faulty protein in Gaucher disease (GD), may be a promising therapeutic approach for the treatment of neurological symptoms associated with GD, according to ... Read more